SCPS [NASD]
Scopus BioPharma Inc.
Index- P/E- EPS (ttm)-1.61 Insider Own50.66% Shs Outstand21.09M Perf Week0.40%
Market Cap8.06M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.41M Perf Month-21.54%
Income-27.00M PEG- EPS next Q- Inst Own4.80% Short Float0.53% Perf Quarter-45.17%
Sales- P/S- EPS this Y-92.20% Inst Trans-66.10% Short Ratio0.18 Perf Half Y-85.35%
Book/sh-0.03 P/B- EPS next Y- ROA- Target Price- Perf Year-95.04%
Cash/sh0.20 P/C2.01 EPS next 5Y- ROE- 52W Range0.36 - 10.64 Perf YTD-75.36%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-96.21% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low11.89% ATR0.05
Employees9 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)35.52 Volatility15.52% 12.08%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.12 Prev Close0.40
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume308.30K Price0.40
Recom2.00 SMA20-11.24% SMA50-31.51% SMA200-82.21% Volume35,826 Change0.73%
Feb-16-21Initiated The Benchmark Company Speculative Buy $20
May-05-22 08:30AM  
Mar-22-22 08:30PM  
Jan-10-22 08:30AM  
Jan-06-22 07:00AM  
Dec-17-21 08:00AM  
Dec-07-21 08:30AM  
Dec-06-21 07:00AM  
Nov-22-21 08:00AM  
Nov-08-21 08:00AM  
Oct-08-21 05:30PM  
Oct-05-21 08:45AM  
Oct-01-21 04:30PM  
07:00AM  
Sep-29-21 08:30AM  
Sep-28-21 09:15AM  
06:30AM  
06:00AM  
Sep-23-21 08:30AM  
Sep-22-21 08:30AM  
Sep-21-21 09:00AM  
Sep-20-21 09:05AM  
Sep-15-21 09:07AM  
Sep-14-21 09:00AM  
Sep-09-21 08:00AM  
Sep-07-21 09:15AM  
Sep-03-21 09:25AM  
Sep-02-21 09:15AM  
Jul-12-21 08:30AM  
Jun-30-21 09:30AM  
May-31-21 08:30PM  
May-26-21 07:30PM  
May-24-21 09:30AM  
Apr-26-21 09:25AM  
Mar-16-21 05:39AM  
Mar-15-21 07:00AM  
Feb-10-21 08:05PM  
Feb-08-21 07:00PM  
Jan-29-21 08:00PM  
Jan-27-21 09:20AM  
Jan-26-21 08:00PM  
Jan-19-21 07:00AM  
Dec-29-20 04:00AM  
Dec-18-20 12:12PM  
10:55AM  
Dec-17-20 12:23PM  
08:59AM  
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor inverse agonist and inhibitor of inducible nitric oxide synthase for the treatment of systemic sclerosis. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greenspan Ira ScottExecutive Committee ChairmanAug 27Buy4.987903,93414,640Aug 30 09:11 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 27Buy4.9211054182,450Aug 30 09:11 AM
Lamstein Joshua RChairmanAug 27Buy5.002001,000119,997Aug 27 06:02 PM
Lamstein Joshua RChairmanAug 26Buy4.90200980119,797Aug 27 06:02 PM
Greenspan Ira ScottExecutive Committee ChairmanAug 24Buy4.655023382,340Aug 25 08:15 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 23Buy4.415002,20582,290Aug 25 08:15 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 20Buy4.234001,69281,790Aug 23 08:24 AM
Greenspan Ira ScottExecutive Committee ChairmanAug 19Buy4.042,0008,08013,850Aug 23 08:24 AM
Lamstein Joshua RChairmanAug 19Buy4.048003,232119,597Aug 23 05:55 PM
Greenspan Ira ScottExecutive Committee ChairmanAug 18Buy4.271,0004,27011,850Aug 19 06:10 PM
Greenspan Ira ScottExecutive Committee ChairmanAug 17Buy4.131,0004,13010,850Aug 19 06:10 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 27Buy4.5420090881,390Jul 27 04:59 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 26Buy4.781,0004,7809,850Jul 27 04:59 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 26Buy4.764001,90481,190Jul 27 04:59 PM
Lamstein Joshua RChairmanJul 23Buy4.711,5007,065118,797Jul 27 04:59 PM
Greenspan Ira ScottExecutive Committee ChairmanJul 23Buy4.771,1005,2478,850Jul 27 04:59 PM